MAPT and Alzheimer disease: As sporadic CAA with and without tau pathology shows distinct clinical profiles and may require different management or monitoring strategies [6, 30], dual‐phase PiB scans may provide a clinically useful tool to identify high‐risk patients with CAA who may also have concomitant AD or be vulnerable to neurodegeneration.